newsfilter
← Latest News
Business Wire·

Contineum Therapeutics to Attend Upcoming Investor Conferences

Contineum Therapeutics, Inc. (NASDAQ:CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological